A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder
Clinical trial NCT05376150 · COMPLETED
Trial details
- NCT number
- NCT05376150
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2023-09-18
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.